Cargando…
Vedolizumab-Associated Hypereosinophilia and Hepatoxicity
Vedolizumab, which is approved for the treatment of ulcerative colitis, has been associated with drug-induced liver injury because of an unclear mechanism. We describe the case of a 29-year-old man who presented with abnormal liver enzymes and peripheral hypereosinophilia after vedolizumab initiatio...
Autores principales: | De Marco, Davide, Bessissow, Talat, Marcus, Victoria, Benmassaoud, Amine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668547/ https://www.ncbi.nlm.nih.gov/pubmed/36404891 http://dx.doi.org/10.14309/crj.0000000000000905 |
Ejemplares similares
-
Cardiac Involvement in Hypereosinophilia Associated with Toxocariasis
por: Park, Hyun-Joon, et al.
Publicado: (2014) -
Hypereosinophilia: A Diagnostic Dilemma
por: Rehman, Habib Ur
Publicado: (2010) -
Thiopurines in the Management of Crohn's Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
por: Benmassaoud, Amine, et al.
Publicado: (2016) -
Successful Use of Antihistamines in Severe Hypereosinophilia
por: Vallero, Stefano, et al.
Publicado: (2012) -
A Case of Pulmonary Thromboembolism Associated With Hypereosinophilia in a Child
por: An, Hyo Soon, et al.
Publicado: (2009)